Interventional Cardiology Market in North America - Annualized Market Revenues (USD), Volume (units) and Average Prices (USD) Data from 2015 to 2025
December 31, 2020 03:53 ET
|
Research and Markets
Dublin, Dec. 31, 2020 (GLOBE NEWSWIRE) -- The "North America Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents and Others" report has been...
United Kingdom Interventional Cardiology Market Databook with Annualized Market Revenues (USD), Volume (units) and Average Prices (USD) Data for Each of the Market Segments
December 23, 2020 02:43 ET
|
Research and Markets
Dublin, Dec. 23, 2020 (GLOBE NEWSWIRE) -- The "United Kingdom Interventional Cardiology Market Outlook to 2025 - Cardiac Catheters, Coronary Guidewires, Coronary Stents and Others" report has been...
Global Percutaneous Coronary Intervention Market Analysis - 2018-2027
November 09, 2020 07:58 ET
|
Research and Markets
Dublin, Nov. 09, 2020 (GLOBE NEWSWIRE) -- The "Global Percutaneous Coronary Intervention Market Outlook 2027" report has been added to ResearchAndMarkets.com's offering. The global percutaneous...
Global Coronary Stent Market to Witness a CAGR of 8.7% during 2019-2025
May 08, 2019 07:53 ET
|
Energias Market Research
NEW YORK, May 08, 2019 (GLOBE NEWSWIRE) -- The global coronary stent market is expected to grow from USD 7,756 million in 2018 to USD 13,907 million in 2025, at a CAGR of 8.7% from 2019 to 2025. The...
Amaranth Presented Interim Nine-Month Follow-up MAGNITUDE (98 micron) and Two-Year Follow-up APTITUDE (115 micron) Data at EuroPCR Symposium
May 23, 2018 08:30 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , May 23, 2018 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, provided...
Amaranth Medical Showcases Breadth of BRS Pipeline at TCT, Unveiling 9-mo Interim Imaging Results from 98 micron MAGNITUDE and Update on 115-micron APTITUDE
October 25, 2017 13:21 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Oct. 25, 2017 (GLOBE NEWSWIRE) -- Amaranth Medical, a medical device company developing next-generation bioresorbable scaffolds for the interventional cardiology market, will...
Amaranth Medical Initiates Trial of Sub-100-Micron MAGNITUDE Sirolimus-Eluting Bioresorbable Scaffold
November 01, 2016 08:00 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, announced the initiation of a clinical study of the Company’s latest-generation...
Global and China Coronary Stent Market to Benefit from Rising Demand for Minimally Invasive Treatments: QYResearchReports.com
July 14, 2016 08:33 ET
|
QY Research Reports
Brooklyn, NY , July 14, 2016 (GLOBE NEWSWIRE) -- The aging population is increasingly accepting minimally invasive surgeries and treatments. Advances in medical devices and the rising government...
Amaranth Medical On Track to Complete Enrollment in RENASCENT-II Study of 120-Micron APTITUDE™ Sirolimus-Eluting Bioresorbable Scaffold in May
May 18, 2016 03:01 ET
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA , May 18, 2016 (GLOBE NEWSWIRE) -- Amaranth Medical, a privately held medical device company, provided a clinical update on its ongoing RENASCENT-II study of its novel APTITUDE™...